-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Taysha Gene Therapies, Inc. annual/quarterly Net Cash Provided by (Used in) Investing Activities history and growth rate from Q3 2019 to Q1 2024.
- Taysha Gene Therapies, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2024 was -$140K, a 96.4% increase year-over-year.
- Taysha Gene Therapies, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2024 was -$363K, a 95.1% increase from 2023.
- Taysha Gene Therapies, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$7.35M, a 70.5% increase from 2022.
- Taysha Gene Therapies, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$24.9M, a 15.7% decline from 2021.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)